COMMUNIQUÉS West-GlobeNewswire

Atara Biotherapeutics’ Tab-cel™ Achieves Positive Long-Term Outcomes in Phase 2 Studies of Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas

15/06/2018 - 08:30

Findings presented at 23rd Congress of European Hematology Association Tab-cel™ demonstrated durable remissions and encouraging safety profile in patients with EBV+ PTLD who failed first line therapy Median survival in [...]

Shire plc : Rule 2.9 Announcement

15/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 June 2018 Shire [...]

BeiGene Provides Development Update and Presents Clinical Data on Zanubrutinib at the 23rd Congress of the European Hematology Association

15/06/2018 - 08:00

Investor Call Scheduled Today, June 15, 2018, at 8:00 am EDT CAMBRIDGE, Mass. and BEIJING, China, June 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on [...]

ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018

15/06/2018 - 07:30

LYON, France, June 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances [...]

Sandoz presents new long-term and switching data for biosimilars Zessly® (infliximab) and Erelzi® (etanercept) in rheumatoid arthritis

15/06/2018 - 07:16

Zessly ® (infliximab) matched the reference medicine in terms of safety and efficacy at 54 weeks, even in patients who switched from the reference medicine to Zessly[1] Switching from the reference medicine to Erelzi [...]

News Release: Notice of first General Meeting of the future EssilorLuxottica

15/06/2018 - 07:01

Notice of first General Meeting of the future EssilorLuxottica PDF version of the news release Charenton-le-Pont, France (June 15, 2018) - At its meeting of June 7, 2018, the Board of Directors of Essilor decided to [...]

Communiqué : Convocation à la première Assemblée Générale de la future société EssilorLuxottica

15/06/2018 - 07:01

Convocation à la première Assemblée Générale de la future société EssilorLuxottica Version PDF du communiqué Charenton-le-Pont, France (le 15 juin 2018) - Le Conseil d'administration d'Essilor, lors de sa réunion du 7 [...]

Zomedica Announces Changes to Commercialization Leadership Team

15/06/2018 - 00:15

ANN ARBOR, Mich., June 14, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced the [...]

Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

14/06/2018 - 23:52

WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call Information

14/06/2018 - 22:44

Conference Call Scheduled for Friday, June 15 at 1:00 PM EDT NORTHVALE, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company [...]

Sorrento Therapeutics issues Chairman/CEO corporate update to stockholders

14/06/2018 - 22:42

SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Dear Sorrento Stockholders, It is with pride that I issue this mid-year update letter to our shareholders. Since the beginning of [...]

Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board

14/06/2018 - 22:30

TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV: PRN) (OTCQX:PRFMF) is pleased to announce the results of the votes on the matters considered at its Annual Meeting [...]

Reata Pharmaceuticals, Inc. Secures $125 Million Term Loan Facility

14/06/2018 - 22:15

IRVING, Texas, June 14, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that it entered into an amended and [...]

Transparency notification

14/06/2018 - 22:02

Mechelen, Belgium; 14 June 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]

Transparency notification pursuant to Article 14 of the Law of May 2, 2007

14/06/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 14, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference

14/06/2018 - 22:01

HAMILTON, Bermuda, June 14, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) announced today that it will be presenting at the JMP Securities 2018 Life Sciences Conference on Thursday, June 21 st , [...]

AGTC Announces Expansion of Clinical and Regulatory Leadership Teams

14/06/2018 - 22:01

20+ Year Medical Affairs and Ophthalmology Veteran, Lanita C. Scott, M.D., Appointed as Vice President of Clinical Research and Medical Affairs Karen M. Carroll, RN, Named Vice President of Clinical Development [...]

Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone

14/06/2018 - 21:20

CALGARY, Alberta, June 14, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has received confirmation from the U.S. Food and Drug Administration (“FDA”) that [...]

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

14/06/2018 - 18:19

NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the recommendations of the [...]